ReP USP - Resultado da busca

Artigo de periodico
Berberine-loaded engineered nanoparticles attenuate TGF-β-induced remodelling in human bronchial epithelial cells (2023)
Rubis, Gabriele De; Paudel, Keshav Raj ; Liu, Gang ; Agarwal, Vishwesh ; MacLoughlin, Ronan ; Pinto, Terezinha de Jesus Andreoli ; Singh, Sachin Kumar ; Adams, Jon ; Nammi, Srinivas ; Chellappan, Dinesh Kumar ; Oliver, Brian Gregory George ; Hansbro, Philip Michael; Dua, Kamal
Source: Toxicology in Vitro. Unidade: FCF
Subjects: NANOPARTÍCULAS, CÉLULAS EPITELIAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RUBIS, Gabriele De et al. Berberine-loaded engineered nanoparticles attenuate TGF-β-induced remodelling in human bronchial epithelial cells. Toxicology in Vitro, v. 92, p. 1-9 art. 105660, 2023Tradução . . Disponível em: https://dx.doi.org/10.1016/j.tiv.2023.105660. Acesso em: 14 nov. 2024.
APA
Rubis, G. D., Paudel, K. R., Liu, G., Agarwal, V., MacLoughlin, R., Pinto, T. de J. A., et al. (2023). Berberine-loaded engineered nanoparticles attenuate TGF-β-induced remodelling in human bronchial epithelial cells. Toxicology in Vitro, 92, 1-9 art. 105660. doi:10.1016/j.tiv.2023.105660
NLM
Rubis GD, Paudel KR, Liu G, Agarwal V, MacLoughlin R, Pinto T de JA, Singh SK, Adams J, Nammi S, Chellappan DK, Oliver BGG, Hansbro PM, Dua K. Berberine-loaded engineered nanoparticles attenuate TGF-β-induced remodelling in human bronchial epithelial cells [Internet]. Toxicology in Vitro. 2023 ; 92 1-9 art. 105660.[citado 2024 nov. 14 ] Available from: https://dx.doi.org/10.1016/j.tiv.2023.105660
Vancouver
Rubis GD, Paudel KR, Liu G, Agarwal V, MacLoughlin R, Pinto T de JA, Singh SK, Adams J, Nammi S, Chellappan DK, Oliver BGG, Hansbro PM, Dua K. Berberine-loaded engineered nanoparticles attenuate TGF-β-induced remodelling in human bronchial epithelial cells [Internet]. Toxicology in Vitro. 2023 ; 92 1-9 art. 105660.[citado 2024 nov. 14 ] Available from: https://dx.doi.org/10.1016/j.tiv.2023.105660
Artigo de periodico
Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review (2021)
Prasher, Parteek ; Sharma, Mousmee ; Zacconi, Flavia ; Gupt, Gaurav ; Aljabali, Alaa A ; Mishra, Vijay ; Tambuwala, Murtaza M ; Kapoor, Deepak N ; Negi, Poonam ; Pinto, Terezinha de Jesus Andreoli ; Singh, Inderbir ; Chellappan, Dinesh Kumar ; Dua, Kamal
Source: Current Organic Chemistry. Unidade: FCF
Subjects: QUIMIOTERÁPICOS, COMPOSTOS HETEROCÍCLICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRASHER, Parteek et al. Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review. Current Organic Chemistry, v. 25, p. 654-668, 2021Tradução . . Disponível em: https://doi.org/10.2174/1385272824999200820152501. Acesso em: 14 nov. 2024.
APA
Prasher, P., Sharma, M., Zacconi, F., Gupt, G., Aljabali, A. A., Mishra, V., et al. (2021). Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review. Current Organic Chemistry, 25, 654-668. doi:10.2174/1385272824999200820152501
NLM
Prasher P, Sharma M, Zacconi F, Gupt G, Aljabali AA, Mishra V, Tambuwala MM, Kapoor DN, Negi P, Pinto T de JA, Singh I, Chellappan DK, Dua K. Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review [Internet]. Current Organic Chemistry. 2021 ; 25 654-668.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2174/1385272824999200820152501
Vancouver
Prasher P, Sharma M, Zacconi F, Gupt G, Aljabali AA, Mishra V, Tambuwala MM, Kapoor DN, Negi P, Pinto T de JA, Singh I, Chellappan DK, Dua K. Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review [Internet]. Current Organic Chemistry. 2021 ; 25 654-668.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2174/1385272824999200820152501
Artigo de periodico
Advanced drug delivery systems targeting NF-κB in respiratory diseases (2021)
Prasher, Parteek ; Sharma, Mousmee ; Chellappan, Dinesh Kumar ; Gupta, Gaurav ; Jha, Niraj Kumar; Singh, Sachin Kumar; MacLoughlin, Ronan ; Pinto, Terezinha de Jesus Andreoli ; Löbenberg, Raimar ; Dua, Kamal
Source: Future Medicinal Chemistry. Unidade: FCF
Subjects: DOENÇAS RESPIRATÓRIAS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRASHER, Parteek et al. Advanced drug delivery systems targeting NF-κB in respiratory diseases. Future Medicinal Chemistry, v. 13, n. 13, p. 1087-1090, 2021Tradução . . Disponível em: https://doi.org/10.4155/fmc-2021-0013. Acesso em: 14 nov. 2024.
APA
Prasher, P., Sharma, M., Chellappan, D. K., Gupta, G., Jha, N. K., Singh, S. K., et al. (2021). Advanced drug delivery systems targeting NF-κB in respiratory diseases. Future Medicinal Chemistry, 13( 13), 1087-1090. doi:10.4155/fmc-2021-0013
NLM
Prasher P, Sharma M, Chellappan DK, Gupta G, Jha NK, Singh SK, MacLoughlin R, Pinto T de JA, Löbenberg R, Dua K. Advanced drug delivery systems targeting NF-κB in respiratory diseases [Internet]. Future Medicinal Chemistry. 2021 ; 13( 13): 1087-1090.[citado 2024 nov. 14 ] Available from: https://doi.org/10.4155/fmc-2021-0013
Vancouver
Prasher P, Sharma M, Chellappan DK, Gupta G, Jha NK, Singh SK, MacLoughlin R, Pinto T de JA, Löbenberg R, Dua K. Advanced drug delivery systems targeting NF-κB in respiratory diseases [Internet]. Future Medicinal Chemistry. 2021 ; 13( 13): 1087-1090.[citado 2024 nov. 14 ] Available from: https://doi.org/10.4155/fmc-2021-0013
Artigo de periodico
Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases (2021)
Chan, Yinghan ; MacLoughlin, Ronan ; Tambuwala, Murtaza M ; Pabari, Ritesh M ; Singh, Sachin Kumar ; Pinto, Terezinha de Jesus Andreoli ; Gupta, Gaurav ; Chellappan, Dinesh Kumar ; Dua, Kamal
Source: Nanomedicine. Unidade: FCF
Subjects: DOENÇAS RESPIRATÓRIAS, NANOTECNOLOGIA, INFLAMAÇÃO, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHAN, Yinghan et al. Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases. Nanomedicine, v. 16, n. 16, p. 1351–1355, 2021Tradução . . Disponível em: https://doi.org/10.2217/nnm-2021-0087. Acesso em: 14 nov. 2024.
APA
Chan, Y., MacLoughlin, R., Tambuwala, M. M., Pabari, R. M., Singh, S. K., Pinto, T. de J. A., et al. (2021). Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases. Nanomedicine, 16( 16), 1351–1355. doi:10.2217/nnm-2021-0087
NLM
Chan Y, MacLoughlin R, Tambuwala MM, Pabari RM, Singh SK, Pinto T de JA, Gupta G, Chellappan DK, Dua K. Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases [Internet]. Nanomedicine. 2021 ; 16( 16): 1351–1355.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2021-0087
Vancouver
Chan Y, MacLoughlin R, Tambuwala MM, Pabari RM, Singh SK, Pinto T de JA, Gupta G, Chellappan DK, Dua K. Advances in nanotechnology-based drug delivery in targeting PI3K signaling in respiratory diseases [Internet]. Nanomedicine. 2021 ; 16( 16): 1351–1355.[citado 2024 nov. 14 ] Available from: https://doi.org/10.2217/nnm-2021-0087

USP Schools

ReP

Filtros

Authors

Subjects

Funding Agencies

Non normalized affiliation

Countries of institutions of collaboration